ES2143180T3 - Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular. - Google Patents

Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular.

Info

Publication number
ES2143180T3
ES2143180T3 ES96901859T ES96901859T ES2143180T3 ES 2143180 T3 ES2143180 T3 ES 2143180T3 ES 96901859 T ES96901859 T ES 96901859T ES 96901859 T ES96901859 T ES 96901859T ES 2143180 T3 ES2143180 T3 ES 2143180T3
Authority
ES
Spain
Prior art keywords
molecular weight
high molecular
granulates
pharmaceutical compositions
release tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901859T
Other languages
English (en)
Inventor
Jean-Pierre Collaueri
Guillaume Conrath
Paul-Joel Derian
Gabriel Gousset
Frederic Mauger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhodia Chimie SAS
Original Assignee
Rhodia Chimie SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie SAS filed Critical Rhodia Chimie SAS
Application granted granted Critical
Publication of ES2143180T3 publication Critical patent/ES2143180T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE SE PRESENTA EN FORMA DE COMPRIMIDOS PREPARADOS POR COMPRESION DIRECTA Y CONSTITUIDOS POR AL MENOS UN PRINCIPIO ACTIVO Y UNA MATRIZ QUE PRODUCE EL EFECTO DE RETARDO EN DICHAS COMPOSICIONES, CARACTERIZADA PORQUE DICHA MATRIZ ESTA CONSTITUIDA AL MENOS PARCIALMENTE POR PREGRANULADOS DE POLISACARIDOS CON GRAN PESO MOLECULAR, DE ORIGEN SINTETICO O NATURAL.
ES96901859T 1995-01-27 1996-01-26 Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular. Expired - Lifetime ES2143180T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500946A FR2729857B1 (fr) 1995-01-27 1995-01-27 Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire

Publications (1)

Publication Number Publication Date
ES2143180T3 true ES2143180T3 (es) 2000-05-01

Family

ID=9475564

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901859T Expired - Lifetime ES2143180T3 (es) 1995-01-27 1996-01-26 Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular.

Country Status (10)

Country Link
US (1) US6221393B1 (es)
EP (1) EP0805676B1 (es)
JP (1) JPH10512873A (es)
AT (1) ATE187640T1 (es)
AU (1) AU4627096A (es)
CA (1) CA2210321C (es)
DE (1) DE69605649T2 (es)
ES (1) ES2143180T3 (es)
FR (1) FR2729857B1 (es)
WO (1) WO1996022767A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
IN186245B (es) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
FR2785191B1 (fr) * 1998-11-02 2002-05-31 Rhodia Chimie Sa Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
BR0210855A (pt) * 2001-07-06 2006-10-24 Penwest Pharmaceuticals Compan Método de fabricação de formulações de liberação prolongada
US9820982B2 (en) * 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
EP1545468A4 (en) * 2002-09-20 2007-06-20 Alpharma Inc SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
UA80872C2 (uk) * 2003-03-31 2007-11-12 Пліва-Лахема А.С. Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
JP4959191B2 (ja) 2003-07-11 2012-06-20 旭化成ケミカルズ株式会社 機能性澱粉粉末
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
EP1909770B1 (en) * 2005-02-22 2013-03-20 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
CN101490093B (zh) * 2006-07-20 2012-07-18 罗迪亚公司 衍生化瓜尔胶的制造方法以及用该方法制得的衍生化瓜尔胶
MX2009003771A (es) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co Formulaciones robustas de liberacion sostenida.
US20080085304A1 (en) * 2006-10-10 2008-04-10 Penwest Pharmaceuticals Co. Robust sustained release formulations
NZ603173A (en) 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
FR3020571B1 (fr) * 2014-05-05 2017-08-25 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Co-granules de gomme de xanthane et de gomme d'acacia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8515484D0 (en) * 1985-06-19 1985-07-24 Shell Int Research Heteropolysaccharide particles
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
FR2600267A1 (fr) * 1986-06-19 1987-12-24 Rhone Poulenc Chimie Granules de biopolymere a dispersabilite et dissolution rapides
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp RELEASED, EXTENDED, EASY TO PRODUCE EXCIPIENT, BASED ON KONJAC GLUCOMANNANE.
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine

Also Published As

Publication number Publication date
EP0805676A1 (fr) 1997-11-12
MX9705611A (es) 1997-10-31
CA2210321C (fr) 2003-03-18
FR2729857A1 (fr) 1996-08-02
DE69605649T2 (de) 2000-06-21
US6221393B1 (en) 2001-04-24
WO1996022767A1 (fr) 1996-08-01
FR2729857B1 (fr) 1997-04-04
CA2210321A1 (fr) 1996-08-01
ATE187640T1 (de) 2000-01-15
DE69605649D1 (de) 2000-01-20
EP0805676B1 (fr) 1999-12-15
AU4627096A (en) 1996-08-14
JPH10512873A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
FR2729857B1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
PT817847E (pt) Receptor de il-17
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
MEP39108A (en) Pharmaceutical composition
DE69723730D1 (de) Pharmazeutische zusammensetzungen, die alkylamide von di- und tricarbonsäuren als gelierungsmittel enthalten
BR0209489A (pt) Composições farmacêuticas
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
NO971206D0 (no) Forlenget-frigjöringsformulering
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR9810495A (pt) Composição farmacêutica
GEP20053616B (en) Polysaccharides with Antithrombotic Activity Comprising At Least one Covalent Bond with Biotin or Biotin Derivative
NO995591L (no) Geler med forsinket, langvarig frigjörelse
AR021806A1 (es) COMPOSICIoN FARMACÉUTICA EN FORMA DE TABLETA QUE COMPRENDE ENTACAPONA Y MÉTODO DE PREPARACIoN.
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
DE69033970D1 (de) Huperzin a analoge verbindungen
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
PT975348E (pt) Composicoes de tibolona estabilizadas
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
ATE352290T1 (de) Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin
ITMI932540A1 (it) Composizione farmaceutica
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
HN1998000045A (es) Composiciones farmaceuticas
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 805676

Country of ref document: ES